Abstract
Objective
Neuroimaging abnormalities in central nervous system (CNS) brucellosis are not well documented. The purpose of this study was to evaluate the prevalence of imaging abnormalities in neurobrucellosis and to identify factors associated with leptomeningeal and basal enhancement, which frequently results in unfavorable outcomes.
Methods
Istanbul-3 study evaluated 263 adult patients with CNS brucellosis from 26 referral centers and reviewed their 242 magnetic resonance imaging (MRI) and 226 computerized tomography (CT) scans of the brain.
Results
A normal CT or MRI scan was seen in 143 of 263 patients (54.3 %). Abnormal imaging findings were grouped into the following four categories: (a) inflammatory findings: leptomeningeal involvements (44), basal meningeal enhancements (30), cranial nerve involvements (14), spinal nerve roots enhancement (8), brain abscesses (7), granulomas (6), and arachnoiditis (4). (b) White-matter involvement: white-matter involvement (32) with or without demyelinating lesions (7). (c) Vascular involvement: vascular involvement (42) mostly with chronic cerebral ischemic changes (37). (d) Hydrocephalus/cerebral edema: hydrocephalus (20) and brain edema (40). On multivariate logistic regression analysis duration of symptoms since the onset (OR 1.007; 95 % CI 1–28, p = 0.01), polyneuropathy and radiculopathy (OR 5.4; 95 % CI 1.002–1.013, p = 0.044), cerebrospinal fluid (CSF)/serum glucose rate (OR 0.001; 95 % CI 000–0.067, p = 0.001), and CSF protein (OR 2.5; 95 % CI 2.3–2.7, p = 0.0001) were associated with diffuse inflammation.
Conclusions
In this study, 45 % of neurobrucellosis patients had abnormal neuroimaging findings. The duration of symptoms, polyneuropathy and radiculopathy, high CSF protein level, and low CSF/serum glucose rate were associated with inflammatory findings on imaging analyses.
Similar content being viewed by others
References
Gul HC, Erdem H. Brucellosis (brucella species). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, douglass, and bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Co; 2015. p. 2584–9.
Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7:775–86.
Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14:e469–78.
Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13:e339–43.
Gul HC, Erdem H, Gorenek L, Ozdag MF, Kalpakci Y, Avci IY, et al. Management of neurobrucellosis: an assessment of 11 cases. Intern Med. 2008;47:995–1001.
Martinez-Chamorro E, Munoz A, Esparza J, Munoz MJ, Giangaspro E. Focal cerebral involvement by neurobrucellosis: pathological and mri findings. Eur J Radiol. 2002;43:28–30.
Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012;56:1523–8.
Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis. A report on 19 cases. Brain. 1987;110:213–23.
Bashir R, Al-Kawi MZ, Harder EJ, Jinkins J. Nervous system brucellosis: diagnosis and treatment. Neurology. 1985;35:1576–81.
Erdem H, Senbayrak S, Gencer S, Hasbun R, Karahocagil MK, Sengoz G, et al. Tuberculous and brucellosis meningitis differential diagnosis. Travel Med Infect Dis. 2015;13:185–91.
Akdeniz H, Irmak H, Anlar O, Demiroz AP. Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect. 1998;36:297–301.
Habeeb YK, Al-Najdi AK, Sadek SA, Al-Onaizi E. Paediatric neurobrucellosis: case report and literature review. J Infect. 1998;37:59–62.
Ozisik HI, Ersoy Y, Refik Tevfik M, Kizkin S, Ozcan C. Isolated intracranial hypertension: a rare presentation of neurobrucellosis. Microbes Infect. 2004;6:861–3.
Yetkin MA, Bulut C, Erdinc FS, Oral B, Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis. 2006;10:446–52.
Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol. 2004;25:395–401.
Kizilkilic O, Calli C. Neurobrucellosis. Neuroimaging Clin N Am. 2011;21:927–37.
Eisenhut M. Vasospasm in cerebral inflammation. Int J Inflam. 2014;2014:509707.
Ozkavukcu E, Tuncay Z, Selcuk F, Erden I. An unusual case of neurobrucellosis presenting with unilateral abducens nerve palsy: clinical and MRI findings. Diagn Interv Radiol. 2009;15:236–8.
Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother. 2015;15:1081–92.
Colmenero JD, Queipo-Ortuno MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J Neurol Neurosurg Psychiatry. 2005;76:1025–7.
Erdem H, Kilic S, Sener B, Acikel C, Alp E, Karahocagil M, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013;19:E80–6.
Tunkel AR. Approach to the patient with central nervous system infection. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglass, and Bennett’s principles and practice of infectious diseases. Philadelphia: Elsevier Co; 2015. p. 1091–6.
McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis. 1992;15:582–90.
Shakir RA. Brucellosis. In: Shakir RA, Neuman PK, Poser CM, editors. Tropical neurology. Cambridge: WB Saunders; 1996. p. 168–79.
Hernandez MA, Anciones B, Frank A. Barreiro P [neurobrucellosis and cerebral vasculitis]. Neurologia. 1988;3:241–3.
Guerreiro CA, Scaff M, Callegaro D, Facure NO, Dianin VM. [neurobrucellosis: report of 3 cases]. Arq Neuropsiquiatr. 1981;39:203–13.
Rajan R, Khurana D, Kesav P. Deep gray matter involvement in neurobrucellosis. Neurology. 2013;80:e28–9.
Mousa AM, Muhtaseb SA, Reddy RR, Senthilselvan A, Al-Mudallal DS, Marafie AA. The high rate of prevalence of ct-detected basal ganglia calcification in neuropsychiatric (cns) brucellosis. Acta Neurol Scand. 1987;76:448–56.
So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol. 1994;35:53–8.
Koffman B, Junck L, Elias SB, Feit HW, Levine SR. Polyradiculopathy in sarcoidosis. Muscle Nerve. 1999;22:608–13.
Shrikanth V, Salazar L, Khoury N, Wootton S, Hasbun R. Hypoglycorrhachia in adults with community-acquired meningitis: etiologies and prognostic significance. Int J Infect Dis. 2015;39:39–43.
Al-Kawi MZ. Brucellosis. In: Moher JP, Gautier J, editors. Guide to clinical neurology. New York: Churchill Livingstone Co; 1995. p. 677–80.
Koussa S, Chemaly R. Neurobrucellosis presenting with diffuse cerebral white matter lesions. Eur Neurol. 2003;50:121–3.
Bektas O, Ozdemir H, Yilmaz A, Fitoz S, Ciftci E, Ince E, et al. An unusual case of neurobrucellosis presenting as demyelination disorder. Turk J Pediatr. 2013;55:210–3.
Kang BH, Lim YM, Kim KK. Brucellosis manifesting as chronic inflammatory demyelinating polyneuropathy. Can J Neurol Sci. 2012;39:536–8.
Bussone G, La Mantia L, Grazzi L, Lamperti E, Salmaggi A, Strada L. Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol. 1989;29:238–40.
Brinar VV, Habek M. Rare infections mimicking ms. Clin Neurol Neurosurg. 2010;112:625–8.
Khorvash F, Keshteli AH, Behjati M, Salehi M, Emami Naeini A. An unusual presentation of brucellosis, involving multiple organ systems, with low agglutinating titers a case report. J Med Case Rep. 2007;1:53.
Greenblatt D, Krupp LB, Belman AL. Parainfectious meningo-encephalo-radiculo-myelitis (cat scratch disease, lyme borreliosis, brucellosis, botulism, legionellosis, pertussis, mycoplasma). Handb Clin Neurol. 2013;112:1195–207.
Martin Escudero JC, Gil Gonzalez MI, Aparicio Blanco M. [Intracranial hypertension and subarachnoid hemorrhage: the forms of presentation of neurobrucellosis]. An Med Interna. 1990;7:358–60.
Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(Suppl 1):S12–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author (Hakan Erdem) states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Erdem, H., Senbayrak, S., Meriç, K. et al. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study. Infection 44, 623–631 (2016). https://doi.org/10.1007/s15010-016-0901-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-016-0901-3